Use of multicolor fluorescence in situ hybridization to detect deletions in clinical tissue sections (2018)
- Authors:
- Autor USP: SQUIRE, JEREMY ANDREW - FMRP
- Unidade: FMRP
- DOI: 10.1038/s41374-017-0007-2
- Subjects: DELEÇÃO DE GENES; HIBRIDIZAÇÃO; GENES SUPRESSORES DE TUMOR; NEOPLASIAS; GENÉTICA
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título: Laboratory Investigation
- ISSN: 0023-6837
- Volume/Número/Paginação/Ano: v. 98, n. 4, p. 403-413, 2018
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
YOSHIMOTO, Maisa et al. Use of multicolor fluorescence in situ hybridization to detect deletions in clinical tissue sections. Laboratory Investigation, v. 98, n. 4, p. 403-413, 2018Tradução . . Disponível em: https://doi.org/10.1038/s41374-017-0007-2. Acesso em: 24 jan. 2026. -
APA
Yoshimoto, M., Ludkovski, O., Good, J., Pereira, C., Gooding, R. J., McGowan-Jordan, J., et al. (2018). Use of multicolor fluorescence in situ hybridization to detect deletions in clinical tissue sections. Laboratory Investigation, 98( 4), 403-413. doi:10.1038/s41374-017-0007-2 -
NLM
Yoshimoto M, Ludkovski O, Good J, Pereira C, Gooding RJ, McGowan-Jordan J, Boag A, Evans A, Tsao M-S, Nuin P, Squire JA. Use of multicolor fluorescence in situ hybridization to detect deletions in clinical tissue sections [Internet]. Laboratory Investigation. 2018 ; 98( 4): 403-413.[citado 2026 jan. 24 ] Available from: https://doi.org/10.1038/s41374-017-0007-2 -
Vancouver
Yoshimoto M, Ludkovski O, Good J, Pereira C, Gooding RJ, McGowan-Jordan J, Boag A, Evans A, Tsao M-S, Nuin P, Squire JA. Use of multicolor fluorescence in situ hybridization to detect deletions in clinical tissue sections [Internet]. Laboratory Investigation. 2018 ; 98( 4): 403-413.[citado 2026 jan. 24 ] Available from: https://doi.org/10.1038/s41374-017-0007-2 - Extracellular vesicles: evolving factors in stem cell biology
- Quantitative assessment of PTEN loss (qPTEN) is strongly associated with biochemical recurrence and may improve treatment decisions after surgery
- In silico shows that PTEN loss and AR overexpression are associated with increased CD8+ T-cell and Treg density and earlier disease recurrence in prostate cancer
- Analytic validation of a clinical-grade PTEN immunohistochemistry assay in prostate cancer by comparison with PTEN FISH
- Quantitative assessment of PTEN loss (qPTEN) is strongly associated with biochemical recurrence and may improve treatment decisions after surgery
- Tumour genomic and microenvironmental heterogeneity for integrated prediction of 5-year biochemical recurrence of prostate cancer: a retrospective cohort study
- Recurrent copy number alterations in prostate cancer: an in silico meta-analysis of publicly available genomic data
- First application of the Automated QUantitative Analysis (AQUA) technique to quantify PTEN protein expression in ovarian cancer: a correlative study of NCIC CTG OV.16
- Digital expression profiling identifies RUNX2, CDC5L, MDM2, RECQL4, and CDK4 as potential predictive biomarkers for neo-adjuvant chemotherapy response in paediatric osteosarcoma
- Recurrent copy number alterations in prostate cancer: an in silico meta-analysis of publicly available genomic data
Informações sobre o DOI: 10.1038/s41374-017-0007-2 (Fonte: oaDOI API)
Download do texto completo
| Tipo | Nome | Link | |
|---|---|---|---|
 |
002948509.pdf |
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
